カテゴリ： Allied Market Research, 世界, 医療/バイオ

ボツリヌス毒素のグローバル市場（2021〜2031）：ボツリヌス毒素A型、ボツリヌス毒素B型

■ 英語タイトル：Botulinum Toxin Market By Product (Botulinum Toxin Type A, Botulinum Toxin Type B), By Application (Aesthetic, Therapeutic), By End User (Hospitals, Specialty and Dermatology Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23FB182）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23FB182
■ 発行日：2022年10月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：215
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ボツリヌス毒素のグローバル市場（2021〜2031）：ボツリヌス毒素A型、ボツリヌス毒素B型]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本市場調査レポートでは、2021年に5814.9百万ドルであった世界のボツリヌス毒素市場規模が、2031年までに13132.72百万ドルに到達し、2022年から2031年にかけてCAGR（年平均成長率）8.6%で成長すると予測しています。本レポートは、ボツリヌス毒素の世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、製品別（ボツリヌス毒素A型、ボツリヌス毒素B型）分析、用途別（美容、治療）分析、エンドユーザー別（病院、専門・皮膚科クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、企業状況、企業情報などを掲載しています。また、本レポートは、REVANCE THERAPEUTICS INC、Medy-Tox, Inc.、GALDERMA、US WORLDMED, LLC、Abbvie Inc (Allergan)、DAEWOONG PHARMACEUTICAL、Ipsen Groupなどの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界のボツリヌス毒素市場規模：製品別
- ボツリヌス毒素A型における市場規模
- ボツリヌス毒素B型における市場規模
・世界のボツリヌス毒素市場規模：用途別
- 美容における市場規模
- 治療における市場規模
・世界のボツリヌス毒素市場規模：エンドユーザー別
- 病院における市場規模
- 専門・皮膚科クリニックにおける市場規模
- その他における市場規模
・世界のボツリヌス毒素市場規模：地域別
- 北米のボツリヌス毒素市場規模
- ヨーロッパのボツリヌス毒素市場規模
- アジア太平洋のボツリヌス毒素市場規模
- 中南米・中東・アフリカのボツリヌス毒素市場規模
・企業状況
・企業情報

世界のボツリヌス毒素市場は、2021年に5億8,140万ドルと評価され、2022年から2031年にかけて年平均成長率8.6%を記録し、2031年には1億3,132万ドルに達すると予測されています。

ボツリヌス毒素は、既知の最も有毒な生物学的物質の1つで、ボツリヌス菌によって産生される神経毒です。ボツリヌス菌は抗原的に区別可能な8種類の外毒素（A、B、C1、C2、D、E、F、G）を産生します。すべての血清型は、神経筋接合部の主要な神経伝達物質であるアセチルコリンの放出を阻害することによって神経伝達を阻害し、筋麻痺を引き起こします。ボツリヌス毒素Aの注射によって誘発される筋力低下は、通常約3ヵ月間持続します。

ボツリヌス毒素は現在、さまざまな病状、特に斜視や局所性ジストニア、内科的治療に部分的にしか反応しないいくつかの慢性疾患の管理において重要な役割を果たしています。新しい適応の可能性は急速に拡大しています。ボツリヌス毒素の注射は、顔、あご、首、胸などのシワやシワの矯正から、多汗症などの皮膚科学的な応用まで、美容的な応用が可能です。ボツリヌストキシンによる注射は一般的に忍容性が高く、副作用はほとんどありません。ボツリヌストキシンを臨床で正しく使用するためには、模倣筋の機能解剖学に関する正確な知識と理解が必要です。

ボツリヌス毒素市場は、美容目的の非侵襲的外科処置の需要の急増、新製品の発売、手頃な価格の増加、ボツリヌス注射をカバーする償還政策の改正により、予測期間中に大きな成長が見込まれています。さらに、ボツリヌス毒素処置の数の増加は、市場の成長をさらに促進します。しかし、ボトックス施術に伴う副作用や施術費用の高さが、新興地域における市場成長の妨げになると予想されます。対照的に、ボツリヌス毒素の治療用途を探求するための主要メーカーによる研究開発活動への投資の増加は、ボツリヌス毒素市場に大きな成長機会を提供すると予想されています。

ボツリヌス毒素市場は、製品、用途、エンドユーザー、地域によって区分されます。製品別では、市場はA型ボツリヌス毒素とB型ボツリヌス毒素に分類されます。用途別では、美容と治療に分けられます。エンドユーザー別では、病院、専門・皮膚科クリニック、その他に分類されます。
地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域）、アジア太平洋地域（日本、中国、オーストラリア、インド、韓国、その他のアジア太平洋地域）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他のLAMEA地域）に市場を分けて分析しています。

本レポートは、世界のボツリヌス毒素市場で事業を展開する主要企業の包括的な分析を提供します。本レポートに掲載されている主要企業には、Merz Pharma GmbH And Co. Kgaa、Abbvie Inc (Allergan)、Ipsen Group、Revance Therapeutics Inc、Medy-Tox, Inc.、Hugel, Inc.、Galderma、Us Worldmed, Llc、Evolus Inc.、Daewoong Pharmaceuticalなどです。

〈ステークホルダーにとっての主なメリット〉
・ボツリヌス毒素の市場機会を特定するため、2021年から2031年までの市場セグメント、現在の動向、予測、ボツリヌス毒素市場分析のダイナミクスを定量的に分析します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・ボツリヌス毒素市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・ボツリヌス毒素の地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
用途別
美容
治療

製品別
A型ボツリヌス毒素
B型ボツリヌス毒素

エンドユーザー別
病院
専門・皮膚科クリニック
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
オーストラリア
インド
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
REVANCE THERAPEUTICS INC
Medy-Tox, Inc.
GALDERMA
US WORLDMED, LLC
Abbvie Inc (Allergan)
DAEWOONG PHARMACEUTICAL
Ipsen Group
MERZ PHARMA GMBH AND CO. KGAA
HUGEL, INC.
EVOLUS INC.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: BOTULINUM TOXIN MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Botulinum Toxin Type A
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Botulinum Toxin Type B
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: BOTULINUM TOXIN MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Aesthetic
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Therapeutic
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: BOTULINUM TOXIN MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Specialty and Dermatology Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: BOTULINUM TOXIN MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product
7.2.5.1.3 Market size and forecast, by Application
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product
7.2.5.2.3 Market size and forecast, by Application
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product
7.2.5.3.3 Market size and forecast, by Application
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product
7.3.5.1.3 Market size and forecast, by Application
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product
7.3.5.2.3 Market size and forecast, by Application
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product
7.3.5.3.3 Market size and forecast, by Application
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product
7.3.5.4.3 Market size and forecast, by Application
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product
7.3.5.5.3 Market size and forecast, by Application
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product
7.3.5.6.3 Market size and forecast, by Application
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product
7.4.5.1.3 Market size and forecast, by Application
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product
7.4.5.2.3 Market size and forecast, by Application
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product
7.4.5.3.3 Market size and forecast, by Application
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product
7.4.5.4.3 Market size and forecast, by Application
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product
7.4.5.5.3 Market size and forecast, by Application
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product
7.4.5.6.3 Market size and forecast, by Application
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product
7.5.5.1.3 Market size and forecast, by Application
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product
7.5.5.2.3 Market size and forecast, by Application
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product
7.5.5.3.3 Market size and forecast, by Application
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product
7.5.5.4.3 Market size and forecast, by Application
7.5.5.4.4 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 REVANCE THERAPEUTICS INC
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Medy-Tox, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 galderma
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 US WORLDMED, LLC
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Abbvie Inc (Allergan)
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 DAEWOONG PHARMACEUTICAL
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Ipsen Group
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 MERZ PHARMA GMBH AND CO. KGAA
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 HUGEL, INC.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 EVOLUS INC.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 2. BOTULINUM TOXIN MARKET FOR BOTULINUM TOXIN TYPE A, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. BOTULINUM TOXIN MARKET FOR BOTULINUM TOXIN TYPE A, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. BOTULINUM TOXIN MARKET FOR BOTULINUM TOXIN TYPE B, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. BOTULINUM TOXIN MARKET FOR BOTULINUM TOXIN TYPE B, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 7. BOTULINUM TOXIN MARKET FOR AESTHETIC, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. BOTULINUM TOXIN MARKET FOR AESTHETIC, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 9. BOTULINUM TOXIN MARKET FOR THERAPEUTIC, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. BOTULINUM TOXIN MARKET FOR THERAPEUTIC, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. GLOBAL BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 12. BOTULINUM TOXIN MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. BOTULINUM TOXIN MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 14. BOTULINUM TOXIN MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. BOTULINUM TOXIN MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 16. BOTULINUM TOXIN MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. BOTULINUM TOXIN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 18. BOTULINUM TOXIN MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. NORTH AMERICA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 20. NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 23. U.S. BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 24. U.S. BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. CANADA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 27. CANADA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 29. MEXICO BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 30. MEXICO BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 32. EUROPE BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 33. EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 34. EUROPE BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 36. GERMANY BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 37. GERMANY BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 38. GERMANY BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. FRANCE BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 40. FRANCE BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 41. FRANCE BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 42. UK BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 43. UK BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 44. UK BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 45. ITALY BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 46. ITALY BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 47. ITALY BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. SPAIN BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 49. SPAIN BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 50. SPAIN BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 51. REST OF EUROPE BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 52. REST OF EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 53. REST OF EUROPE BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 54. ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 55. ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 57. ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 58. JAPAN BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 59. JAPAN BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 60. JAPAN BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 61. CHINA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 62. CHINA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 63. CHINA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 64. AUSTRALIA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 65. AUSTRALIA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 66. AUSTRALIA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 67. INDIA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 68. INDIA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 69. INDIA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 70. SOUTH KOREA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 71. SOUTH KOREA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 72. SOUTH KOREA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 73. REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 74. REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 75. REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 76. LAMEA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 77. LAMEA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 78. LAMEA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 79. LAMEA BOTULINUM TOXIN MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 80. BRAZIL BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 81. BRAZIL BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 82. BRAZIL BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 83. SAUDI ARABIA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 84. SAUDI ARABIA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SAUDI ARABIA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SOUTH AFRICA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 87. SOUTH AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 88. SOUTH AFRICA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 89. REST OF LAMEA BOTULINUM TOXIN MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 90. REST OF LAMEA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF LAMEA BOTULINUM TOXIN MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 92.REVANCE THERAPEUTICS INC: COMPANY SNAPSHOT
TABLE 93.REVANCE THERAPEUTICS INC: OPERATING SEGMENTS
TABLE 94.REVANCE THERAPEUTICS INC: PRODUCT PORTFOLIO
TABLE 95.REVANCE THERAPEUTICS INC: NET SALES
TABLE 96.REVANCE THERAPEUTICS INC: KEY STRATERGIES
TABLE 97.MEDY-TOX, INC.: COMPANY SNAPSHOT
TABLE 98.MEDY-TOX, INC.: OPERATING SEGMENTS
TABLE 99.MEDY-TOX, INC.: PRODUCT PORTFOLIO
TABLE 100.MEDY-TOX, INC.: NET SALES
TABLE 101.MEDY-TOX, INC.: KEY STRATERGIES
TABLE 102.GALDERMA: COMPANY SNAPSHOT
TABLE 103.GALDERMA: OPERATING SEGMENTS
TABLE 104.GALDERMA: PRODUCT PORTFOLIO
TABLE 105.GALDERMA: NET SALES
TABLE 106.GALDERMA: KEY STRATERGIES
TABLE 107.US WORLDMED, LLC: COMPANY SNAPSHOT
TABLE 108.US WORLDMED, LLC: OPERATING SEGMENTS
TABLE 109.US WORLDMED, LLC: PRODUCT PORTFOLIO
TABLE 110.US WORLDMED, LLC: NET SALES
TABLE 111.US WORLDMED, LLC: KEY STRATERGIES
TABLE 112.ABBVIE INC (ALLERGAN): COMPANY SNAPSHOT
TABLE 113.ABBVIE INC (ALLERGAN): OPERATING SEGMENTS
TABLE 114.ABBVIE INC (ALLERGAN): PRODUCT PORTFOLIO
TABLE 115.ABBVIE INC (ALLERGAN): NET SALES
TABLE 116.ABBVIE INC (ALLERGAN): KEY STRATERGIES
TABLE 117.DAEWOONG PHARMACEUTICAL: COMPANY SNAPSHOT
TABLE 118.DAEWOONG PHARMACEUTICAL: OPERATING SEGMENTS
TABLE 119.DAEWOONG PHARMACEUTICAL: PRODUCT PORTFOLIO
TABLE 120.DAEWOONG PHARMACEUTICAL: NET SALES
TABLE 121.DAEWOONG PHARMACEUTICAL: KEY STRATERGIES
TABLE 122.IPSEN GROUP: COMPANY SNAPSHOT
TABLE 123.IPSEN GROUP: OPERATING SEGMENTS
TABLE 124.IPSEN GROUP: PRODUCT PORTFOLIO
TABLE 125.IPSEN GROUP: NET SALES
TABLE 126.IPSEN GROUP: KEY STRATERGIES
TABLE 127.MERZ PHARMA GMBH AND CO. KGAA: COMPANY SNAPSHOT
TABLE 128.MERZ PHARMA GMBH AND CO. KGAA: OPERATING SEGMENTS
TABLE 129.MERZ PHARMA GMBH AND CO. KGAA: PRODUCT PORTFOLIO
TABLE 130.MERZ PHARMA GMBH AND CO. KGAA: NET SALES
TABLE 131.MERZ PHARMA GMBH AND CO. KGAA: KEY STRATERGIES
TABLE 132.HUGEL, INC.: COMPANY SNAPSHOT
TABLE 133.HUGEL, INC.: OPERATING SEGMENTS
TABLE 134.HUGEL, INC.: PRODUCT PORTFOLIO
TABLE 135.HUGEL, INC.: NET SALES
TABLE 136.HUGEL, INC.: KEY STRATERGIES
TABLE 137.EVOLUS INC.: COMPANY SNAPSHOT
TABLE 138.EVOLUS INC.: OPERATING SEGMENTS
TABLE 139.EVOLUS INC.: PRODUCT PORTFOLIO
TABLE 140.EVOLUS INC.: NET SALES
TABLE 141.EVOLUS INC.: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ビデオ喉頭鏡のグローバル市場（2021〜2031）：固定型、汎用型
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23FB182 )"ボツリヌス毒素のグローバル市場（2021〜2031）：ボツリヌス毒素A型、ボツリヌス毒素B型" (英文：Botulinum Toxin Market By Product (Botulinum Toxin Type A, Botulinum Toxin Type B), By Application (Aesthetic, Therapeutic), By End User (Hospitals, Specialty and Dermatology Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。